Literature DB >> 12113060

Individualized cancer therapy: molecular approaches to the prediction of tumor response.

Howard L McLeod1.   

Abstract

A major issue with current cancer therapy is how to ensure the maximum benefit with minimum toxicity for individual patients. With the progress of the human genome project have come high-throughput technologies for the analysis of DNA, gene expression or tumor protein in an efficient and quantitative manner. This review will highlight areas of progress with use of molecular approaches to improve the prediction of tumor response, towards the goal of optimized therapy for each individual patient.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12113060     DOI: 10.1586/14737140.2.1.113

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  4 in total

Review 1.  Role of cytochrome P450 activity in the fate of anticancer agents and in drug resistance: focus on tamoxifen, paclitaxel and imatinib metabolism.

Authors:  Bertrand Rochat
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

Review 2.  Methods and goals for the use of in vitro and in vivo chemosensitivity testing.

Authors:  Rosalyn D Blumenthal; David M Goldenberg
Journal:  Mol Biotechnol       Date:  2007-02       Impact factor: 2.695

Review 3.  Metabolomic studies of human gastric cancer: review.

Authors:  Naresh Doni Jayavelu; Nadav S Bar
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

4.  Phase I and pharmacokinetic study of irinotecan in combination with R115777, a farnesyl protein transferase inhibitor.

Authors:  A Sparreboom; D F S Kehrer; R H J Mathijssen; R Xie; M J A de Jonge; P de Bruijn; A S T Planting; F A L M Eskens; C Verheij; G de Heus; A Klaren; S Zhang; T Verhaeghe; P A Palmer; J Verweij
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.